Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C

Aims. Long-term risk stratification using combined liver stiffness (LS) and clinically relevant blood tests acquired at the baseline further beyond the sustained virologic response (SVR) visit for chronic hepatitis C (CHC) has not been thoroughly investigated. This study retrospectively investigated...

Full description

Saved in:
Bibliographic Details
Main Authors: Sheng-Hung Chen, Hsueh-Chou Lai, Wen-Pang Su, Jung-Ta Kao, Po-Heng Chuang, Wei-Fan Hsu, Hung-Wei Wang, Tsung-Lin Hsieh, Hung-Yao Chen, Cheng-Yuan Peng
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2022/5201443
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558315776770048
author Sheng-Hung Chen
Hsueh-Chou Lai
Wen-Pang Su
Jung-Ta Kao
Po-Heng Chuang
Wei-Fan Hsu
Hung-Wei Wang
Tsung-Lin Hsieh
Hung-Yao Chen
Cheng-Yuan Peng
author_facet Sheng-Hung Chen
Hsueh-Chou Lai
Wen-Pang Su
Jung-Ta Kao
Po-Heng Chuang
Wei-Fan Hsu
Hung-Wei Wang
Tsung-Lin Hsieh
Hung-Yao Chen
Cheng-Yuan Peng
author_sort Sheng-Hung Chen
collection DOAJ
description Aims. Long-term risk stratification using combined liver stiffness (LS) and clinically relevant blood tests acquired at the baseline further beyond the sustained virologic response (SVR) visit for chronic hepatitis C (CHC) has not been thoroughly investigated. This study retrospectively investigated the prognostics of liver-related events (LREs) further beyond the SVR visit. Methods. Cox regression and random forest models identified the key factors, including longitudinal LS and noninvasive test results, that could predict LREs, including hepatocellular carcinoma, during prespecified follow-ups from 2010 to 2021. Kaplan–Meier survival analysis estimated the significance of between-group risk stratification. Results. Of the entire eligible cohort (n = 520) of CHC patients with SVR to antiviral therapy, 28 (5.4%) patients developed post-SVR LREs over a median follow-up period of 6.1 years (interquartile range = 3.5–8.7). The multivariate Cox regression analysis identified two significant predictors of LREs after the year 3 post-SVR (Y3PSVR) baseline (LRE, n = 15 of 28, 53.6%, median follow-up = 4.1 [1.6–6.4] years after Y3PSVR): LS at Y3PSVR (adjusted hazard ratio [aHR] = 3.980, 95% confidence interval [CI] = 2.085–7.597, P<0.001), and α-fetoprotein (AFP) at Y3PSVR (aHR = 1.017, 95% CI = 1.001–1.034, P=0.034). LS ≥1.45 m/s and AFP ≥3.00 ng/mL for Y3PSVR yielded positive likelihood ratios of 4.24 and 2.62, respectively. Kaplan–Meier analysis revealed that among the stratified subgroups, the subgroup with concurrent LS ≥1.45 m/s and AFP ≥3.00 ng/mL at Y3PSVR exhibited the highest risk of LREs after Y3PSVR (log-rank P<0.001). Conclusion. We recommend the combined use of concurrent LS and AFP in future prediction models for LREs in CHC. Patients with concurrently high LS and AFP values further beyond the SVR visit may require a recall policy involving intense surveillance.
format Article
id doaj-art-5214548ac190418186a4b35148f178ee
institution Kabale University
issn 2291-2797
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-5214548ac190418186a4b35148f178ee2025-02-03T01:32:37ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27972022-01-01202210.1155/2022/5201443Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis CSheng-Hung Chen0Hsueh-Chou Lai1Wen-Pang Su2Jung-Ta Kao3Po-Heng Chuang4Wei-Fan Hsu5Hung-Wei Wang6Tsung-Lin Hsieh7Hung-Yao Chen8Cheng-Yuan Peng9Department of MedicineCenter for Digestive MedicineCenter for Digestive MedicineDepartment of MedicineCenter for Digestive MedicineCenter for Digestive MedicineDepartment of MedicineCenter for Digestive MedicineDepartment of MedicineDepartment of MedicineAims. Long-term risk stratification using combined liver stiffness (LS) and clinically relevant blood tests acquired at the baseline further beyond the sustained virologic response (SVR) visit for chronic hepatitis C (CHC) has not been thoroughly investigated. This study retrospectively investigated the prognostics of liver-related events (LREs) further beyond the SVR visit. Methods. Cox regression and random forest models identified the key factors, including longitudinal LS and noninvasive test results, that could predict LREs, including hepatocellular carcinoma, during prespecified follow-ups from 2010 to 2021. Kaplan–Meier survival analysis estimated the significance of between-group risk stratification. Results. Of the entire eligible cohort (n = 520) of CHC patients with SVR to antiviral therapy, 28 (5.4%) patients developed post-SVR LREs over a median follow-up period of 6.1 years (interquartile range = 3.5–8.7). The multivariate Cox regression analysis identified two significant predictors of LREs after the year 3 post-SVR (Y3PSVR) baseline (LRE, n = 15 of 28, 53.6%, median follow-up = 4.1 [1.6–6.4] years after Y3PSVR): LS at Y3PSVR (adjusted hazard ratio [aHR] = 3.980, 95% confidence interval [CI] = 2.085–7.597, P<0.001), and α-fetoprotein (AFP) at Y3PSVR (aHR = 1.017, 95% CI = 1.001–1.034, P=0.034). LS ≥1.45 m/s and AFP ≥3.00 ng/mL for Y3PSVR yielded positive likelihood ratios of 4.24 and 2.62, respectively. Kaplan–Meier analysis revealed that among the stratified subgroups, the subgroup with concurrent LS ≥1.45 m/s and AFP ≥3.00 ng/mL at Y3PSVR exhibited the highest risk of LREs after Y3PSVR (log-rank P<0.001). Conclusion. We recommend the combined use of concurrent LS and AFP in future prediction models for LREs in CHC. Patients with concurrently high LS and AFP values further beyond the SVR visit may require a recall policy involving intense surveillance.http://dx.doi.org/10.1155/2022/5201443
spellingShingle Sheng-Hung Chen
Hsueh-Chou Lai
Wen-Pang Su
Jung-Ta Kao
Po-Heng Chuang
Wei-Fan Hsu
Hung-Wei Wang
Tsung-Lin Hsieh
Hung-Yao Chen
Cheng-Yuan Peng
Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C
Canadian Journal of Gastroenterology and Hepatology
title Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C
title_full Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C
title_fullStr Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C
title_full_unstemmed Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C
title_short Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C
title_sort combined liver stiffness and α fetoprotein further beyond the sustained virologic response visit as predictors of long term liver related events in patients with chronic hepatitis c
url http://dx.doi.org/10.1155/2022/5201443
work_keys_str_mv AT shenghungchen combinedliverstiffnessandafetoproteinfurtherbeyondthesustainedvirologicresponsevisitaspredictorsoflongtermliverrelatedeventsinpatientswithchronichepatitisc
AT hsuehchoulai combinedliverstiffnessandafetoproteinfurtherbeyondthesustainedvirologicresponsevisitaspredictorsoflongtermliverrelatedeventsinpatientswithchronichepatitisc
AT wenpangsu combinedliverstiffnessandafetoproteinfurtherbeyondthesustainedvirologicresponsevisitaspredictorsoflongtermliverrelatedeventsinpatientswithchronichepatitisc
AT jungtakao combinedliverstiffnessandafetoproteinfurtherbeyondthesustainedvirologicresponsevisitaspredictorsoflongtermliverrelatedeventsinpatientswithchronichepatitisc
AT pohengchuang combinedliverstiffnessandafetoproteinfurtherbeyondthesustainedvirologicresponsevisitaspredictorsoflongtermliverrelatedeventsinpatientswithchronichepatitisc
AT weifanhsu combinedliverstiffnessandafetoproteinfurtherbeyondthesustainedvirologicresponsevisitaspredictorsoflongtermliverrelatedeventsinpatientswithchronichepatitisc
AT hungweiwang combinedliverstiffnessandafetoproteinfurtherbeyondthesustainedvirologicresponsevisitaspredictorsoflongtermliverrelatedeventsinpatientswithchronichepatitisc
AT tsunglinhsieh combinedliverstiffnessandafetoproteinfurtherbeyondthesustainedvirologicresponsevisitaspredictorsoflongtermliverrelatedeventsinpatientswithchronichepatitisc
AT hungyaochen combinedliverstiffnessandafetoproteinfurtherbeyondthesustainedvirologicresponsevisitaspredictorsoflongtermliverrelatedeventsinpatientswithchronichepatitisc
AT chengyuanpeng combinedliverstiffnessandafetoproteinfurtherbeyondthesustainedvirologicresponsevisitaspredictorsoflongtermliverrelatedeventsinpatientswithchronichepatitisc